Dr Reddy’s Laboratories enters nutrition segment with ‘Celevida’ in India
The brand ‘Celevida’ is derived from two words ‘celebration’ and ‘vida’, which means ‘celebrate life’. It is available in two…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Reddy’s Laboratories
IPA appoints Satish Reddy as President of IPA for 2019-2021
Dr Rajesh Jain will continue to be as the Vice President
Indian Pharmaceutical Alliance (IPA) recently announced the names of the…
Dr Reddy’s Lab gets EIR from US FDA for Vizag units
The US FDA gives EIR on closure of inspection of an establishment that is the subject of an USFDA or US FDA-contracted inspection
Dr Reddy’s launches anti-smoking drug in USA market
The drug is a therapeutically equivalent generic version of Zyban which is indicated for treatment of nicotine dependence as an…
Dr Reddy’s launches generic oral anti-epileptic drug in US
The product is a generic version of Lundbeck's Sabril powder for oral solution
Dr Reddy’s launches Roche’s Avastin biosimilar in India
The company now has six biosimilar products commercialised in India and various emerging markets
US FDA completes audit of Dr Reddy’s Louisiana-based facility
No Form 483 was issued at the end of the inspection, the company said in a regulatory filing, the company said
FDA grants approvals for generic Lyrica
The FDA granted approvals for the generic versions of Lyrica to Alembic Pharmaceuticals, Alkem Laboratories, Amneal…
Dr Reddy’s announces closure of the transaction to divest Zembrace SymTouch and Tosymra to…
The transaction, including the applicable waiting period, was completed under the Hart-Scott-Rodino Antitrust Improvements Act of…
Dr Reddy’s launches generic version of Allegra D in US
"We are pleased to be expanding our pseudoephedrine-based product offering in time for the cough, cold and allergy season," Dr…